Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase
References (52)
Polypeptide growth factors and atherosclerosis
Trends Cardiovasc. Med.
(1991)- et al.
Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor
J. Biol. Chem.
(1980) - et al.
Relationship between mevalonate and mitogenesis in human fibroblasts stimulated with platelet-derived growth factor
J. Biol. Chem.
(1984) - et al.
The dual role of mevalonate in the cell cycle
J. Biol. Chem.
(1983) - et al.
Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth
J. Lipid Res.
(1980) - et al.
Relationships among dolichyl phosphate, glycoprotein synthesis, and cell culture growth
Arch. Biochem. Biophys.
(1990) - et al.
Inhibition by 6fluoromevalonate demonstrates that mevalonate or one of the mevalonate phosphates is necessary for lymphocyte proliferation
J. Biol. Chem.
(1990) - et al.
Simvastatin but not pravastatin inhibits the proliferation of rat aorta myocytes
Pharm. Res.
(1991) - et al.
Lipophilic β-adrenoceptor antagonists stimulate cholesterol biosynthesis in human skin fibroblasts
Biochem. Pharmacol.
(1987) - et al.
Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase
J. Biol. Chem.
(1978)
Protein measurement with the Folin phenol reagent
J. Biol. Chem.
(1951)
Selective inhibition of cholesterol synthesis in liver versus extrahepatic tissues by HMG-CoA reductase inhibitors
J. Lipid Res.
(1990)
Prenyl proteins in eukaryotic cells: a new type of membrane anchor
Trends Biochem. Sci.
(1990)
Biochemistry of protein prenylation
J. Lipid Res.
(1992)
Evidence for post-translational incorporation of a product of mevalonic acid into Swiss 3T3 cell proteins
J. Biol. Chem.
(1984)
All ras proteins are polyisoprenylated but only some are palmitoylated
Cell
(1989)
Post-translational isoprenylation of cellular proteins is altered in response to mevalonate availability
J. Biol. Chem.
(1989)
Differential inhibitory effects of lovastatin on protein isoprenylation and sterol synthesis
J. Biol. Chem.
(1990)
Human lamin B contains a farnesylated cysteine residue
J. Biol. Chem.
(1989)
Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation
J. Am. Coll. Cardiol.
(1990)
Prevention of restenosis by lovastatin after succesful coronary angioplasty
Am. Heart J.
(1991)
The pathogenesis of atherosclerosis. An update
N. Engl. J. Med.
(1986)
Update on the pathogenesis of atherosclerosis
Am. J. Med.
(1991)
Regulation of mevalonate pathway
Nature
(1990)
Posttranslational modification of proteins by isoprenoids in mammalian cells
FASEB J.
(1990)
Requirement for mevalonate in cycling cells: quantitative and temporal aspects
J. Cell. Physiol.
(1988)
Cited by (0)
Copyright © 1993 Published by Elsevier Ltd.